Researchers at Columbia University Irving Medical Center have developed eye drops that could prevent vision loss after retinal vein occlusion, a major cause of blindness for millions of adults worldwide.
Jun 29, 2020
0
177
Patients with high cholesterol and triglycerides who underwent spinal, cardiac or orthopedic surgery were at greater risk of waking up blind, reports a new Northwestern Medicine study.
Dec 2, 2021
0
28
New research shows that a treatment for retinal vein occlusion yields long-lasting vision gains, with visual acuity remaining significantly above baseline at five years. However, many patients require ongoing treatment. Retinal ...
Apr 21, 2022
0
14
Eye surgeons at University Hospitals Leuven have been the first to use a surgical robot to operate on a patient with retinal vein occlusion. The robot uses a needle of barely 0.03 millimetre to inject a thrombolytic drug ...
Jan 26, 2017
0
8
Retinitis pigmentosa is a degenerative disease affecting the photoreceptor cells in the retina, known as cones and rods. Of genetic origin, this disease first affects vision in low light conditions, and progressively peripheral ...
May 31, 2022
0
39
New artificial intelligence (AI) technology that detects subtle changes in the retina could prove a game-changer in helping millions of people avoid vision loss or blindness.
Dec 7, 2022
0
25
(HealthDay)—The first biosimilar to Lucentis (ranibizumab injection) has been approved for the treatment of neovascular (wet) age-related macular degeneration and other eye diseases and conditions, the U.S. Food and Drug ...
Sep 24, 2021
0
11
Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the treatment of central retinal vein occlusion (CRVO), according to a clinical trial funded by the National ...
May 9, 2017
0
0
(HealthDay)—Retinal vein occlusion (RVO) is associated with an increased risk for cardiovascular events and all-cause mortality, according to a review published in the September issue of Retina.
Sep 9, 2019
0
3
Since February 2015, aflibercept (trade name Eylea) has been available also for patients with impaired vision due to macular oedema that follows blockage of branch veins of the central retinal vein (branch retinal vein occlusion, ...
Jun 23, 2015
0
4
